International Registry of Patients With Alpha Thalassemia
Recruiting now
Conditions studied: Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor
In brief
This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.
Key facts
- Study ID
- NCT04872179
- Run by
- University of California, San Francisco
- People needed
- 500
- Starts
- 2017-01-01
- Expected to finish
- 2037-01-01
- Last updated by the study team
- 2025-04-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of alpha thalassemia (prenatal or postnatal) with genotype consistent with ATM or BHFS phenotype
- referred to the University of California, San Francisco Fetal Treatment Center for fetal diagnosis, management and/or evaluation for the ongoing in utero stem cell transplantation clinical trial
You may not qualify if…
- none
Where it is running
- University of California San Francisco — San Francisco, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.